Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Sell
9,688
-576
-6% -$205K 0.06% 112
2025
Q4
$3.36M Buy
10,264
+964
+10% +$306K 0.06% 122
2025
Q3
$2.62M Buy
9,300
+289
+3% +$83.8K 0.05% 137
2025
Q2
$2.52M Buy
9,011
+744
+9% +$211K 0.06% 129
2025
Q1
$2.58M Buy
8,267
+354
+4% +$105K 0.07% 115
2024
Q4
$2.06M Sell
7,913
-233
-3% -$69.1K 0.06% 124
2024
Q3
$2.62M Buy
+8,146
New +$2.66M 0.07% 104
2024
Q2
Sell
-7,997
Closed -$2.27M 120
2024
Q1
$2.27M Buy
+7,997
New +$2.34M 0.07% 103
2023
Q4
Sell
-7,904
Closed -$2.12M 106
2023
Q3
$2.12M Buy
7,904
+162
+2% +$40.4K 0.07% 115
2023
Q2
$1.72M Sell
7,742
-194
-2% -$45K 0.06% 118
2023
Q1
$1.92M Sell
7,936
-357
-4% -$87.6K 0.07% 111
2022
Q4
$2.18M Buy
8,293
+240
+3% +$64.3K 0.08% 110
2022
Q3
$1.81M Buy
8,053
+286
+4% +$69.3K 0.07% 104
2022
Q2
$1.89M Buy
7,767
+207
+3% +$50.7K 0.07% 113
2022
Q1
$1.83M Sell
7,560
-1,477
-16% -$339K 0.06% 125
2021
Q4
$2.03M Sell
9,037
-201
-2% -$42.4K 0.06% 126
2021
Q3
$1.96M Buy
9,238
+269
+3% +$61.9K 0.07% 122
2021
Q2
$2.19M Buy
8,969
+25
+0.3% +$6.15K 0.08% 118
2021
Q1
$2.23M Buy
8,944
+6,982
+356% +$1.67M 0.1% 108
2020
Q4
$451K Sell
1,962
-54
-3% -$12.4K 0.03% 157
2020
Q3
$513K Buy
2,016
+80
+4% +$19.8K 0.04% 131
2020
Q2
$457K Sell
1,936
-131
-6% -$29.9K 0.04% 119
2020
Q1
$419K Sell
2,067
-753
-27% -$164K 0.06% 110
2019
Q4
$680K Buy
2,820
+200
+8% +$44.1K 0.09% 107
2019
Q3
$507K Buy
+2,620
New +$503K 0.06% 146

Other funds holding AMGN

Evoke Wealth's AMGN Position: Q1 2026 in Review

Evoke Wealth reduced its Amgen (AMGN) stake by 5.6% in Q1 2026, selling an estimated $205K and leaving 9,688 shares worth $3.41M. The position accounts for 0.06% of the portfolio, ranked #112.

Evoke Wealth first reported a position in AMGN in Q3 2019 and has held it in 25 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Evoke Wealth held 9,688 shares of Amgen worth $3.41M as of Q1 2026.
  • Evoke Wealth sold 576 Amgen shares in Q1 2026, an estimated $205K.
  • Amgen made up 0.06% of Evoke Wealth's portfolio in Q1 2026, its #112 holding.
  • Evoke Wealth first reported a position in Amgen in Q3 2019 and has held it in 25 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.